Compare Alphabet Inc Class A (GOOGL) vs TransMedics Group Inc (TMDX) Price & Performance

Alphabet Inc Class ATrade

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs TransMedics Group Inc — how do they compare? Alphabet Inc Class A trades at $371.87 (market cap $4.52T), while TransMedics Group Inc trades at $76.88 (market cap $2.61B). The key difference: Alphabet Inc Class A is far larger — about 1731.8× TransMedics Group Inc's market cap, and Alphabet Inc Class A pays a 0.24% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

	GOOGL	TMDX
Market Cap	$4.52T	$2.61B
Sector	Media	Technology
52-Week High	$402.62	$150.42
52-Week Low	$182.97	$61.99
Enterprise Value	$4.49T	$3.01B
Dividend Yield	0.24%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOGL

Edge AI software market to hit $8.89B by 2031, growing at 24.4% CAGR driven by real-time AI demand.Marketsandmarkets™ · 3 hours agoBullish Google expands AI Mode to link apps like Instacart, Canva, and YouTube for task completion.TechCrunch · 5 hours agoBullish Google renames NotebookLM to Gemini Notebook, adds interactive coding for data analysis.TechCrunch · 5 hours agoBullish View details →

TMDX

View details →

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.